| Dr Michael Evan Margolis, MD | |
|
280 Exempla Cir, Lafayette, CO 80026-3370 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Dr Michael Evan Margolis |
|---|---|
| Gender | Male |
| Speciality | Surgery - Surgery Of The Hand |
| Location | 280 Exempla Cir, Lafayette, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548223365 | NPI | - | NPPES |
| 019006 | Other | CO | KAISER COMMERCIAL NUMBER |
| 356346 | Medicaid | AZ | |
| 60302577 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 46405 (Colorado) | Secondary |
| 2086S0105X | Surgery - Surgery Of The Hand | 46405 (Colorado) | Primary |
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
Watson Pharmaceuticals, Inc. today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009. Excluding special items as detailed in the reconciliation table below, adjusted net income for the third quarter was $76.1 million, or $0.66 per diluted share, an increase of $22.1 million or 41 percent over the adjusted net income for the third quarter ended September 30, 2008. As detailed in the attached reconciliation table, adjusted EBITDA for the third quarter was $178.4 million.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
To demonstrate its continued commitment to innovative immunoglobulin (Ig) research, CSL Behring announced today it has created the Interlaken Leadership Awards. This global awards program will provide monetary grants to advance medical research and knowledge about the potential role of immunoglobulin therapy in the treatment of neurologic disorders.
The back-to-school movement is in full swing. As parents scour stores for the year's school supplies, the Academy of Nutrition and Dietetics encourages them to stock up on healthy breakfast foods, too.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Evan Margolis, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: () - | Dr Michael Evan Margolis, MD 280 Exempla Cir, Lafayette, CO 80026-3370 Ph: (303) 338-4545 |
News Archive
Watson Pharmaceuticals, Inc. today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009. Excluding special items as detailed in the reconciliation table below, adjusted net income for the third quarter was $76.1 million, or $0.66 per diluted share, an increase of $22.1 million or 41 percent over the adjusted net income for the third quarter ended September 30, 2008. As detailed in the attached reconciliation table, adjusted EBITDA for the third quarter was $178.4 million.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
To demonstrate its continued commitment to innovative immunoglobulin (Ig) research, CSL Behring announced today it has created the Interlaken Leadership Awards. This global awards program will provide monetary grants to advance medical research and knowledge about the potential role of immunoglobulin therapy in the treatment of neurologic disorders.
The back-to-school movement is in full swing. As parents scour stores for the year's school supplies, the Academy of Nutrition and Dietetics encourages them to stock up on healthy breakfast foods, too.
› Verified 7 days ago
Barbara D Mullen, Surgery Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 720-536-7050 | |
Brian P Murphy, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Kelly P Knudson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Exempla Cir, Suite 360, Lafayette, CO 80026 Phone: 303-689-6560 Fax: 303-689-6550 | |
Kenneth Barry Platnick, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Exempla Cir, Suite 360, Lafayette, CO 80026 Phone: 303-689-6560 Fax: 303-689-6550 | |
Terry M Gilliland, Surgery Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-861-3152 | |
Dr. Jeffrey B Leftwich, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Paul William Suding, M.D Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Exempla Cir, Suite 360, Lafayette, CO 80026 Phone: 303-689-6560 Fax: 303-689-6550 |